BACKGROUND: Circulating tumor cells (CTCs) are cells that detach from a primary tumor, circulate through the blood stream and lymphatic vessels, and are considered to be the main reason for remote metastasis. Due to their origin, tumor cells have different gene expression levels than the surrounding blood cells. Therefore, they might be detectable in blood samples from breast cancer patients by real-time quantitative polymerase chain reaction (RT-qPCR). MATERIALS AND METHODS: Blood samples of healthy donors and adjuvant breast cancer patients were withdrawn and the cell fraction containing white blood cells and tumor cells was enriched by density gradient centrifugation. RNA was isolated and reverse transcribed to cDNA, which was then used in TaqMan real-time PCR against cytokeratin (CK)8, CK18 and CK19. 18S and GAPDH were used as controls. RESULTS: All 3 CKs were, on average, found to be significantly higher expressed in adjuvant breast cancer samples compared to negative controls, probably due to the presence of CTCs. Unfortunately, gene expression levels could not be correlated to tumor characteristics. CONCLUSIONS: RT-qPCR could make up a new approach for the detection of CTCs from blood samples of breast cancer patients, but a correlation of the PCR data to gold standard methods in CTC detection would help to further improve the informative value of the qPCR results.
BACKGROUND: Circulating tumor cells (CTCs) are cells that detach from a primary tumor, circulate through the blood stream and lymphatic vessels, and are considered to be the main reason for remote metastasis. Due to their origin, tumor cells have different gene expression levels than the surrounding blood cells. Therefore, they might be detectable in blood samples from breast cancerpatients by real-time quantitative polymerase chain reaction (RT-qPCR). MATERIALS AND METHODS: Blood samples of healthy donors and adjuvant breast cancerpatients were withdrawn and the cell fraction containing white blood cells and tumor cells was enriched by density gradient centrifugation. RNA was isolated and reverse transcribed to cDNA, which was then used in TaqMan real-time PCR against cytokeratin (CK)8, CK18 and CK19. 18S and GAPDH were used as controls. RESULTS: All 3 CKs were, on average, found to be significantly higher expressed in adjuvant breast cancer samples compared to negative controls, probably due to the presence of CTCs. Unfortunately, gene expression levels could not be correlated to tumor characteristics. CONCLUSIONS: RT-qPCR could make up a new approach for the detection of CTCs from blood samples of breast cancerpatients, but a correlation of the PCR data to gold standard methods in CTC detection would help to further improve the informative value of the qPCR results.
Entities:
Keywords:
Adjuvant breast cancer; Circulating tumor cells; Cytokeratins; RT-qPCR
Authors: Michael Zebisch; Alexandra C Kölbl; Ulrich Andergassen; Stephan Hutter; Julia Neugebauer; Verena Engelstädter; Maria Günthner-Biller; Udo Jeschke; Klaus Friese; Brigitte Rack Journal: Biomed Rep Date: 2012-12-05
Authors: D F Hayes; T M Walker; B Singh; E S Vitetta; J W Uhr; S Gross; C Rao; G V Doyle; L W M M Terstappen Journal: Int J Oncol Date: 2002-11 Impact factor: 5.650
Authors: Simon A Joosse; Juliane Hannemann; Julia Spötter; Andreas Bauche; Antje Andreas; Volkmar Müller; Klaus Pantel Journal: Clin Cancer Res Date: 2012-01-06 Impact factor: 12.531
Authors: Anieta M Sieuwerts; Jaco Kraan; Joan Bolt-de Vries; Petra van der Spoel; Bianca Mostert; John W M Martens; Jan-Willem Gratama; Stefan Sleijfer; John A Foekens Journal: Breast Cancer Res Treat Date: 2008-12-30 Impact factor: 4.872
Authors: Aliki Stathopoulou; Anna Gizi; Maria Perraki; Stella Apostolaki; Nikos Malamos; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou Journal: Clin Cancer Res Date: 2003-11-01 Impact factor: 12.531
Authors: N Androulakis; S Agelaki; M Perraki; S Apostolaki; V Bozionelou; A Pallis; K Kalbakis; A Xyrafas; D Mavroudis; V Georgoulias Journal: Br J Cancer Date: 2012-06-05 Impact factor: 7.640
Authors: I Van der Auwera; D Peeters; I H Benoy; H J Elst; S J Van Laere; A Prové; H Maes; P Huget; P van Dam; P B Vermeulen; L Y Dirix Journal: Br J Cancer Date: 2009-12-01 Impact factor: 7.640